Top Stories

As Bluebird backpedals from Europe, small gene and cell therapy players face tough hurdles

After Bluebird Bio (BLUE) announced plans this week to end commercial operations in Europe, the move is raising fresh questions about the extent to …

Read more @ www.statnews.com

Back to top button